Sanofi iAwards Program

iAwards Program Call for Pre-Proposals:  Deadline September 7, 2018

We are pleased to announce the fourth annual call for pre-proposals for the Sanofi iAwards Program, which supports research ideas early in the translational path at the transition between basic research and first proof of concept.

The iAwards program provides $125,000 in research funding for a one-year study, and successful projects have the potential to grow into sponsored research agreements with significantly increased funding and timelines. Over the past 3 years, 17 projects have been funded at BWH and MGH across a diverse range of therapeutic areas.

Research areas of interest: immune-oncology, molecular oncology, immunology & inflammation, rare diseases, neurosciences, diabetes and cardiovascular diseases. In addition, pre-proposals in technology areas including gene therapy, single-cell analysis and biologics development will also be considered.

Please see attached flyer for detailed research areas of interest and further information.

Funding & Term: $125,000 (total amount including indirect costs) over one year.


  • Please use the attached template, and limit your pre-proposal to two pages, excluding publications.
  • Only the JSSC and select members of Sanofi and your Institution will have access to your preproposal. However, information in the pre-proposal is NOT considered confidential and therefore unpublished information should not be disclosed.
  • No third-party collaborators, except for other iAward partner institutions (listed in the flyer), are permitted.

Submit your pre-proposal to before September 7th, 2018.

Please reach out to Julian Peat at for further information.

We look forward to working with you in submitting innovative, early-translation projects to be funded by the Sanofi iAwards Program!

Strategic Alliances Team, Partners Innovation